Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Antibacterial Agents
Phage therapy examined as treatment option for diarrheal disease
August 26th, 2005
Phage therapy was examined as a treatment option for diarrheal disease. "Fifteen healthy adult volunteers received in their drinking water a lower Escherichia coli phage T4 dose (103 PFU/ml), a higher phage dose (105 PFU/ml), and placebo," explained researchers in Switzerland. "Fecal coliphage was detected in a dose-dependent way in volunteers orally exposed to phage." "All volunteers receiving the higher phage dose showed fecal phage 1 day after exposure; this prevalence was only 50% in subjects receiving the lower phage dose," observed A. Bruttin and colleagues, writing in the journal Antimicrobial Agents and...
Source: Drug Week (2005-08-26)
|
